Naldemedine
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications
Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 04, 2026
Peripherally Acting Mu-Opioid Receptor Antagonist Use in Opioid-Induced Constipation in Patients With Cancer: A Scoping Review.
Journal: Clinical journal of oncology nursing
Published: June 02, 2026
Cost-Effectiveness of Prophylactic Naldemedine for Opioid-Induced Constipation in Patients with Cancer.
Journal: Journal of palliative medicine
Published: April 10, 2026
Comparison of Diarrhea Incidence Following Initial Naldemedine Administration in Patients Receiving Strong Opioids: A Retrospective Cohort Study.
Journal: Journal of pain & palliative care pharmacotherapy
Published: March 26, 2026
Can Naldemedine Allow Higher Oxycodone Dosing in Patients with Cancer? A Single-Center Retrospective Study.
Journal: Journal of palliative medicine
Published: February 17, 2026
Multi-Target Inhibition of F10/F2/PAR1 Through In Silico Drug Repurposing of Avodart and Naldemedine to Prevent Thrombotic-Induced Sudden Cardiac Arrest.
Journal: Biomedicines
Published: February 12, 2026
Current Strategies and Future Perspectives in the Management of Opioid-Induced Constipation: A Review of International and Japanese Guidelines.
Journal: Neurogastroenterology and motility
Published: January 19, 2026
German Expert Consensus on Opioid-Induced Constipation (OIC): Recommendations and a Treatment Algorithm for Clinical Practice.
Journal: Journal of clinical medicine
Published: January 16, 2026
The effectiveness and safety of naldemedine in treating opioid-induced constipation among non-cancer adult patients: updated meta-analysis.
Journal: Expert opinion on drug safety
Published: December 25, 2025
Naldemedine (Rizmoic®) for the treatment of opioid-induced constipation
Journal: Revue medicale de Liege
Published: November 13, 2025
Naldemedine for the Prevention of Recurrent Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial.
Journal: United European gastroenterology journal
Published: September 19, 2025
Dose-dependent association of naldemedine and magnesium oxide in the management of opioid-induced constipation.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 04, 2025
Last Updated: 06/30/2026